Gyros Protein Technologies AB has introduced a new kit designed to streamline the detection of pre-existing antibodies against adeno-associated virus (AAV) vectors. The Gyrolab Generic Anti-Adeno Associated Virus (AAV) Kit aims to facilitate qualitative assessment of binding antibodies in both pre-clinical and clinical settings, supporting the development of AAV-based gene therapies.
Indica Labs, a global leader in AI-powered digital pathology solutions, has announced a significant update to its life sciences software suite. The 4.0 versions of HALO®, HALO AI, and HALO Link offer enhanced capabilities for researchers and pathologists, with a focus on leveraging advanced AI-powered image analysis in an open digital pathology ecosystem.
Thermo Fisher Scientific has introduced a groundbreaking solution for more precise blood genotyping in clinical research. The Applied Biosystems™ Axiom™ BloodGenomiX™ Array and Software offers a single, high-throughput assay capable of detecting most extended and rare blood groups, as well as tissue (HLA) and platelet (HPA) types.
DiaSorin has announced that its LIAISON PLEX® Yeast Blood Culture (BCY) Assay has received 510(k) clearance from the US Food and Drug Administration (FDA). This marks the second molecular multiplexing panel to be cleared for the company’s LIAISON PLEX® system, following the clearance of the Respiratory Flex Assay in March 2024.
Siemens Healthineers has announced the CE marking of its Neurofilament Light Chain (NfL) assay for multiple sclerosis (MS) management. Developed in collaboration with Novartis Pharma AG, this blood test is designed for use on the Atellica IM Analyzer and the ADVIA Centaur XP/XPT Systems.
Bio-Rad Laboratories has expanded its portfolio of molecular quality controls with the introduction of Exact Diagnostics GBS Positive and Negative Run Controls. These new products complement the previously launched Exact Diagnostics GBS Verification & Validation Panel, offering clinical laboratories a comprehensive solution for Group B Streptococcus (GBS) molecular assay quality management.
The UNIQO 160, an advanced automation system for indirect immunofluorescence assays (IFA), now incorporates AI-based evaluation of results. This innovation enables complete walkaway automation from primary sample to result proposal, significantly enhancing efficiency and standardisation in IFA analysis.
UK-based toxicology specialist Contract Research Organisation (CRO) Gentronix has been awarded the prestigious King’s Award for Enterprise for 2024 in recognition of its remarkable international trade performance. The Alderley Park-based firm has demonstrated exceptional growth in overseas earnings, with a 239% increase over the past three years.
UK-based biotechnology firm Nuclera has been awarded two Innovate UK grants totalling £1.14 million to further develop its eProtein Discovery system. The funding comprises a £790,000 flexible, agile, scalable, and sustainable technologies (FASST) grant and a £350,000 Engineering Biology grant.
The Celonic Group, a Swiss-based contract development and manufacturing organisation (CDMO) specialising in quality biologics, has inaugurated its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland. This expansion aims to support pharmaceutical companies in developing and optimising processes using advanced bioprocessing technologies.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
